| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |